Copart (CPRT) Q2 2026 earnings review
Growth Engine Stalls: First Revenue Decline in Recent Memory
Copart's growth story hit a wall in Q2, swinging from stagnation in Q1 (+0.7%) to outright contraction (-3.6%) in Q2. The damage was centralized in the core U.S. market, where service revenues fell nearly 6%. Consequently, negative operating leverage kicked in: revenue fell faster than expenses, compressing operating margins to 34.7% from 36.6% a year ago. Net income dropped nearly 10%. While the company sits on a massive $5.1B cash pile, the fundamental volume drivers (insurance assignments) appear to be deteriorating faster than pricing can offset.
🐂 Bull Case
The international segment is decoupling from U.S. weakness. International service revenues grew 7.7% YoY to $132.6M, suggesting the global total loss frequency thesis remains intact outside the U.S.
Copart ended the quarter with $5.1B in cash and restricted cash, up significantly from $2.8B at FY25 year-end (largely due to liquidating held-to-maturity securities). This provides unmatched ammunition for M&A or buybacks.
🐻 Bear Case
U.S. Service Revenues—the highest margin proxy for volume and fees—fell 5.6%. This validates concerns from Q1 regarding insurance carrier share shifts and consumer retrenchment (dropping coverage).
Expenses are sticky. While revenue dropped 3.6%, total operating expenses only declined 0.6%. This rigidity caused operating income to fall 8.8%, a faster rate than the topline decline.
⚖️ Verdict: 🔴
Bearish. The growth thesis is broken in the short term. The pivot from +23% earnings growth in 25Q4 to -10% in 26Q2 is severe. Until U.S. insurance volumes stabilize, the stock lacks a fundamental catalyst.
Key Themes
U.S. Service Revenue Contraction
The core U.S. business is shrinking. U.S. Service Revenue dropped to $819M from $868M (-5.6%). In Q1, management cited 'carrier share shifts' and 'consumer retrenchment' (fewer insured drivers) as headwinds. Q2 data suggests these issues have accelerated, overpowering any pricing (ASP) benefits that supported prior quarters.
Margin Compression Cycle
Operating margin compressed by ~190 basis points YoY (36.6% to 34.7%). The driver is fixed cost deleveraging: Facility operations expenses fell only 2.7% while revenue fell 3.6%. General & Administrative expenses actually rose 3.2% to $89M despite the sales drop, indicating an inability to cut overheads as fast as volume is falling.
International Segment Outperformance
International markets remain a bright spot. Total international revenue (Service + Vehicle Sales) reached $200M, up 6.1% YoY. International service revenue specifically grew 7.7%, showing that the 'Total Loss Frequency' thesis is still working abroad even as it falters in the U.S.
Liquidity Restructuring
Copart aggressively moved out of investments into cash. 'Investment in held to maturity securities' dropped from $2.0B in July 2025 to $0 in Jan 2026, while Cash/Equivalents swelled to $5.1B. This liquidity consolidation suggests preparation for major capital deployment—either a massive buyback or a significant acquisition—though management has historically been conservative.
Other KPIs
Reversing. Down 8.8% YoY. This is a sharp reversal from the +12% growth seen in the comparable quarter last year (25Q2). The decline in profitability is outpacing the decline in revenue due to sticky G&A costs.
Decelerating. Down 10.0% YoY. Buybacks were minimal (share count dropped only 0.3%), offering no support to per-share numbers.
Stable/Slight Decline. Down 1.4% YoY. This segment (vehicles Copart owns and sells) held up better than Service Revenues (-4.0%), likely due to higher mix of international activity or decent scrap pricing, but it remains a small portion of the total mix.
Guidance
Copart does not provide specific numerical guidance. However, the trajectory is clearly Decelerating. Revenue growth has moved from +5.2% (25Q4) to +0.7% (26Q1) to -3.6% (26Q2). Unless U.S. insurance volumes rebound immediately, Q3 is at risk of continued contraction.
Key Questions
U.S. Volume Floor
U.S. Service revenue dropped nearly 6%. Is this solely due to the 'insurance share shift' mentioned in Q1, and when do we lap these losses to find a volume floor?
Expense Rigidity
With revenue falling, G&A expenses actually rose 3.2%. Why is the company unable to flex costs down in response to lower volumes?
Capital Deployment Plans
You liquidated $2B in securities to hold $5.1B in cash. Is this specifically for a pending acquisition, or a change in treasury management strategy?